CLBT Surpasses Important Moving Average Threshold
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 13 2025
0mins
Should l Buy CLBT?
Source: NASDAQ.COM
- 52 Week Range: CLBT's stock has a 52-week low of $13.10 and a high of $26.30, with the last trade recorded at $19.62.
- Moving Average: The article mentions other stocks that have recently crossed above their 200-day moving average.
- Author's Opinion: The views expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
- Stock Performance Insight: The information provides insight into CLBT's stock performance within the context of its 52-week range.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLBT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLBT
Wall Street analysts forecast CLBT stock price to rise
7 Analyst Rating
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.760
Low
23.00
Averages
24.83
High
28.00
Current: 13.760
Low
23.00
Averages
24.83
High
28.00
About CLBT
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cellebrite to Participate in Morgan Stanley Conference
- Conference Participation: Cellebrite will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026, showcasing its leadership in digital investigative and intelligence solutions, which is expected to attract investor interest.
- Executive Attendance: CFO David Barter and VP of Investor Relations Andrew Kramer will speak at the conference, elaborating on the company's strategy and future direction, thereby enhancing market confidence.
- Technological Edge: Cellebrite's AI-powered software supports over 1.5 million legally sanctioned investigations annually, improving operational efficiency and security for clients, highlighting its significance in global law enforcement and intelligence sectors.
- Global Trust: With over 7,000 global law enforcement agencies and enterprises relying on Cellebrite's solutions, the company plays a crucial role in community protection and data privacy, further solidifying its market position.
See More
Cellebrite to Participate in Morgan Stanley Conference
- Conference Participation: Cellebrite will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026, showcasing its leadership in digital investigative and intelligence solutions, which is expected to attract investor interest.
- Executive Attendance: CFO David Barter and VP of Investor Relations Andrew Kramer will speak at the conference, elaborating on the company's strategy and future direction, thereby enhancing market confidence.
- Technological Advantage: Cellebrite's AI-powered software supports over 1.5 million legally sanctioned investigations annually, improving operational efficiency for global law enforcement and enterprises, highlighting its significance in public safety and data privacy protection.
- Global Trust: Over 7,000 global law enforcement agencies and enterprises trust Cellebrite's solutions, indicating widespread application and market recognition in the digital investigation field, further solidifying its industry leadership.
See More
"Exploring Vibe-Coding in Gas Town: A Guide to the Software Market Decline Featuring 4 Attractive Stock Selections."
Market Trends: There has been a significant selloff in software stocks, particularly affecting software-as-a-service (SaaS) companies.
Cultural References: Various playful terms have emerged to describe the situation, such as "SaaSpocalypse," highlighting the dramatic nature of the declines.
Timing of Declines: The downturn in software stocks began in January, indicating that the issues are not solely recent developments.
Naming Challenges: Attempts to create catchy phrases to describe the selloff, like "Valentine’s Day SaaSsacre" and "SaaSquatch," have faced challenges in relevance and accuracy.
See More
Cellebrite Reports Strong Q4 2025 Earnings with Strategic Acquisitions
- Significant Revenue Growth: Cellebrite's Q4 2025 revenue reached $128.8 million, an 18% increase year-over-year, including approximately $1 million from the Corellium acquisition, indicating strong market demand in the digital forensics sector.
- Strong Free Cash Flow: The company reported a full-year free cash flow of $160 million, representing a 30% growth over 2024, with a free cash flow margin of 34%, providing ample funding for future investments and acquisitions.
- Strategic Acquisitions Advance: Cellebrite completed the acquisition of Corellium, enhancing its capabilities in mobile forensics, and announced the acquisition of SCG Canada, further expanding its position in drone forensics, aligning with the company's long-term strategic direction.
- Optimistic 2026 Outlook: Cellebrite projects its annual recurring revenue (ARR) for 2026 to be between $567 million and $573 million, reflecting an 18% to 19% growth rate, demonstrating the company's confidence in future growth and sustained market demand.
See More
Cellebrite Q4 Earnings Exceed Expectations with Strong Revenue Growth
- Significant Revenue Growth: Cellebrite reported Q4 revenue of $128.82 million, an 18.2% year-over-year increase that exceeded market expectations by $2.75 million, indicating strong demand and competitiveness in the digital forensics market.
- Strong Subscription Revenue: The company achieved subscription revenue of $115.5 million, up 21% year-over-year, demonstrating Cellebrite's success in establishing a sustainable revenue stream, which enhances its long-term financial stability.
- Annual Recurring Revenue Increase: Cellebrite's total ARR reached $480.8 million, a 21% increase year-over-year, including $16.1 million from Corellium, showcasing the strategic value and integration capabilities of its acquisition.
- Optimistic Future Outlook: The company projects Q1 2026 ARR to be between $491 million and $493 million, with full-year revenue expected to range from $565 million to $571 million, reflecting management's confidence in future growth and market potential.
See More
Cellebrite Reports Significant Growth in FY 2025 Performance
- ARR Growth: Cellebrite's annual recurring revenue (ARR) surged by 21% to $480.8 million, reflecting strong expansion across all major markets and robust performance of its flagship offerings, solidifying its leadership in digital forensics.
- Revenue and Net Income Increase: Total revenue rose by 18% to $128.8 million in 2025, with net income at $21.3 million supporting a non-GAAP net income of $36.7 million, indicating significant achievements in optimizing resource allocation and customer relationships.
- Adjusted EBITDA Performance: Adjusted EBITDA reached $38.3 million with a 29.8% margin, enhancing the company's profitability and providing strong cash flow support for future investments and expansions.
- Optimistic 2026 Outlook: Cellebrite anticipates ARR to reach $491 million to $493 million in 2026, with a growth rate of 20% to 21%, showcasing ongoing growth potential in global law enforcement, defense, and intelligence sectors, particularly in drone forensics and AI analytics innovations.
See More
Cellebrite to Participate in Morgan Stanley Conference
- Conference Participation: Cellebrite will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026, showcasing its leadership in digital investigative and intelligence solutions, which is expected to attract investor interest.
- Executive Attendance: CFO David Barter and VP of Investor Relations Andrew Kramer will speak at the conference, elaborating on the company's strategy and future direction, thereby enhancing market confidence.
- Technological Edge: Cellebrite's AI-powered software supports over 1.5 million legally sanctioned investigations annually, improving operational efficiency and security for clients, highlighting its significance in global law enforcement and intelligence sectors.
- Global Trust: With over 7,000 global law enforcement agencies and enterprises relying on Cellebrite's solutions, the company plays a crucial role in community protection and data privacy, further solidifying its market position.
See More
Cellebrite to Participate in Morgan Stanley Conference
- Conference Participation: Cellebrite will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026, showcasing its leadership in digital investigative and intelligence solutions, which is expected to attract investor interest.
- Executive Attendance: CFO David Barter and VP of Investor Relations Andrew Kramer will speak at the conference, elaborating on the company's strategy and future direction, thereby enhancing market confidence.
- Technological Advantage: Cellebrite's AI-powered software supports over 1.5 million legally sanctioned investigations annually, improving operational efficiency for global law enforcement and enterprises, highlighting its significance in public safety and data privacy protection.
- Global Trust: Over 7,000 global law enforcement agencies and enterprises trust Cellebrite's solutions, indicating widespread application and market recognition in the digital investigation field, further solidifying its industry leadership.
See More
"Exploring Vibe-Coding in Gas Town: A Guide to the Software Market Decline Featuring 4 Attractive Stock Selections."
Market Trends: There has been a significant selloff in software stocks, particularly affecting software-as-a-service (SaaS) companies.
Cultural References: Various playful terms have emerged to describe the situation, such as "SaaSpocalypse," highlighting the dramatic nature of the declines.
Timing of Declines: The downturn in software stocks began in January, indicating that the issues are not solely recent developments.
Naming Challenges: Attempts to create catchy phrases to describe the selloff, like "Valentine’s Day SaaSsacre" and "SaaSquatch," have faced challenges in relevance and accuracy.
See More
Cellebrite Reports Strong Q4 2025 Earnings with Strategic Acquisitions
- Significant Revenue Growth: Cellebrite's Q4 2025 revenue reached $128.8 million, an 18% increase year-over-year, including approximately $1 million from the Corellium acquisition, indicating strong market demand in the digital forensics sector.
- Strong Free Cash Flow: The company reported a full-year free cash flow of $160 million, representing a 30% growth over 2024, with a free cash flow margin of 34%, providing ample funding for future investments and acquisitions.
- Strategic Acquisitions Advance: Cellebrite completed the acquisition of Corellium, enhancing its capabilities in mobile forensics, and announced the acquisition of SCG Canada, further expanding its position in drone forensics, aligning with the company's long-term strategic direction.
- Optimistic 2026 Outlook: Cellebrite projects its annual recurring revenue (ARR) for 2026 to be between $567 million and $573 million, reflecting an 18% to 19% growth rate, demonstrating the company's confidence in future growth and sustained market demand.
See More
Cellebrite Q4 Earnings Exceed Expectations with Strong Revenue Growth
- Significant Revenue Growth: Cellebrite reported Q4 revenue of $128.82 million, an 18.2% year-over-year increase that exceeded market expectations by $2.75 million, indicating strong demand and competitiveness in the digital forensics market.
- Strong Subscription Revenue: The company achieved subscription revenue of $115.5 million, up 21% year-over-year, demonstrating Cellebrite's success in establishing a sustainable revenue stream, which enhances its long-term financial stability.
- Annual Recurring Revenue Increase: Cellebrite's total ARR reached $480.8 million, a 21% increase year-over-year, including $16.1 million from Corellium, showcasing the strategic value and integration capabilities of its acquisition.
- Optimistic Future Outlook: The company projects Q1 2026 ARR to be between $491 million and $493 million, with full-year revenue expected to range from $565 million to $571 million, reflecting management's confidence in future growth and market potential.
See More
Cellebrite Reports Significant Growth in FY 2025 Performance
- ARR Growth: Cellebrite's annual recurring revenue (ARR) surged by 21% to $480.8 million, reflecting strong expansion across all major markets and robust performance of its flagship offerings, solidifying its leadership in digital forensics.
- Revenue and Net Income Increase: Total revenue rose by 18% to $128.8 million in 2025, with net income at $21.3 million supporting a non-GAAP net income of $36.7 million, indicating significant achievements in optimizing resource allocation and customer relationships.
- Adjusted EBITDA Performance: Adjusted EBITDA reached $38.3 million with a 29.8% margin, enhancing the company's profitability and providing strong cash flow support for future investments and expansions.
- Optimistic 2026 Outlook: Cellebrite anticipates ARR to reach $491 million to $493 million in 2026, with a growth rate of 20% to 21%, showcasing ongoing growth potential in global law enforcement, defense, and intelligence sectors, particularly in drone forensics and AI analytics innovations.
See More
